Articles by Jill Wechsler - Pharmaceutical Executive

ADVERTISEMENT

Articles by Jill Wechsler

Challenge and Challenges

Dec 1, 2008

To expand health coverage amid an economic crisis, Obama will be looking hard for ways to cut costs

Resolving Conflicting Interests

Financial links to biomedical researchers may lead to stiffer disclosure rules for pharma and challenges for research partnerships
Nov 1, 2008

As Congress moves to curb industry influence, support for med ed is waning

Part D Under Attack

Oct 1, 2008

Congressional leaders ready campaign to curb Medicare drug plans.

Foreign Affairs

Sep 1, 2008

FDA missteps and global outsourcing are drawing Congressional scrutiny and prompting new oversight approaches

Can Sentinel Save Drug Development?

Aug 1, 2008

FDA's new sentinel system shows the pendulum swing toward safety won't swing back anytime soon

Smooth Sailing for Orphans

Rare disease treatments are riding high as patient advocates, pharma companies, and government officials celebrate the ODA's 25th anniversary
Jul 1, 2008

Rare disease treatments are riding high as patient adcovates, pharma companies, and government officials celebrate the ODA's 25th anniversary

Candidates Target Pharma

Jun 1, 2008

US presidential hopefuls look to comparative effectiveness analysis to address price and access issues

Dial FDA: Marketers Face Added DTC Requirements

May 21, 2008

Feds consider adding an 800 number to television ads for adverse event reporting. Does this shine light on DTC ads while pushing public health goals? Industry is mum on the topic

FDA to Congress: "Show Us The Money"

May 1, 2008

FDA is being pressured to get its act together. The agency says it needs more money and more people to get approvals out the door

ADVERTISEMENT

Click here